What You Should Know
- The News: SimonMed Imaging is rebranding and launching a new division, SimonMed Longevity, dedicated to AI-enabled preventive screening and whole-body MRIs.
- The Scale: Unlike boutique longevity clinics, SimonMed is leveraging its massive footprint to scale these services rapidly—starting with 30 locations and expanding to 70 by Q1 2026.
- The Tech: The program builds on the company’s previous “simonONE” offering, utilizing exclusively 3T MRI technology and AI protocols to identify health risks before they become symptomatic.
SimonMed Takes Whole-Body MRI National
One of the largest outpatient imaging providers in the United States, SimonMed announced a sweeping rebrand and the launch of SimonMed Longevity, a new division dedicated to AI-enabled preventive care. By integrating the high-end screening services previously siloed under its “simonONE” brand directly into its national infrastructure, SimonMed is attempting to operationalize longevity.
“Preventive imaging shouldn’t be a standalone offering—it should be part of routine healthcare,” said Dr. John Simon, Founder and CEO.
Scaling the Strategy: 70 Sites by 2026
The significance of this launch lies in the scale. While most longevity clinics operate one or two bespoke locations, SimonMed is turning its existing network into a preventive engine.
The new division will launch immediately at 30 locations nationwide, with an aggressive roadmap to expand to more than 70 sites by the end of Q1 2026. This rapid deployment suggests that the demand for proactive health screening has crossed the chasm from “early adopter” to “early majority.”
The offering is designed for patients who want to take control of their long-term well-being, offering a tiered portfolio of screening packages that look for cancer, metabolic disease, and other anomalies long before symptoms appear.
The Tech Stack: 3T MRI Meets AI
Critically, SimonMed is distinguishing its offering through hardware and software superiority. The longevity screenings will be powered exclusively by 3T MRI technology—which offers twice the magnetic field strength of standard 1.5T machines, resulting in clearer, more detailed images.
But hardware is only half the equation. The “Longevity” division is heavily leveraging AI-enabled imaging protocols. In a preventive context, AI is crucial; looking for a needle in a haystack (a small tumor in a healthy person) is difficult for the human eye alone. AI algorithms act as a second set of eyes, flagging potential risks for the board-certified radiologists interpreting the scans.
“Today, those same technologies allow us not only to diagnose and treat disease earlier, but to identify risk sooner,” Dr. Simon noted.
